KDR and hepatocellular carcinoma: Apatinib is an oral tyrosine kinase inhibitor of VEGFR-2 that can induce autophagy [18] and apoptosis, and suppresses tumor proliferation in anaplastic thyroid cancer [8], hepatocellular carcinoma [19], and osteosarcoma [20].